Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies — Stella

Home/Pseudomonas Aeruginosa/

View on ClinicalTrials.gov

Recruiting

Back to Pseudomonas Aeruginosa trials

Trial locations(1 site)

France

Chu Grenoble Alpes, Grenoble

Key details

Sponsor

University Hospital, Grenoble

Enrollment target

~30 participants

Started

October 2020

Primary completion

October 2026

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.